Our data on the channel subunits underlying the TTX-S current in human DRG neurons also has important implications given the recent focus on NaV1.7 as a potential therapeutic target for the treatment of pain based on the human channelopathy data (Dib-Hajj et al., 2013). This evidence concerns the gene SCN9A and channelopathy.